FDA Seeks Civil Money Penalties From Worldwide Medical, Firm's Executives
This article was originally published in The Gray Sheet
Executive Summary
FDA affirmed its regulatory authority over home-use drugs-of-abuse assays in an October 1999 letter to Worldwide Medical that preceded its recent civil money penalty action against the firm, FDA reports.